Articles

Polymorphism in TGFB1 is associated with worse non-relapse mortality and overall survival after stem cell transplantation with unrelated donors

Anthony Nolan Research Institute, London, UK;Cancer Institute, University College London, UK;Centro de Investigaciones en Hematología y Trastornos Afines (CIHATA), Universidad de Costa Rica, San José, Costa Rica
Anthony Nolan Research Institute, London, UK;Cancer Institute, University College London, UK
Anthony Nolan Research Institute, London, UK;Cancer Institute, University College London, UK
Anthony Nolan Research Institute, London, UK;Cancer Institute, University College London, UK
Haematology Department, Hammersmith Hospital, London, UK
BSBMT Data Registry, Guy’s Hospital, London, UK
Department of Haematology, University College London, Royal Free Campus, UK
Adult BMT Unit, University Hospitals Bristol NHS Trust, Bristol, UK
Bone Marrow Transplant Unit, Beatson West of Scotland Cancer Centre, Glasgow, UK
BSBMT Data Registry, Guy’s Hospital, London, UK
Section of Haemato-oncology, Royal Marsden Hospital, London, UK
Centre for Clinical Haematology, Nottingham University Hospital, and Academic Haematology, Nottingham University Hospitals, UK
Department of Haematology, University College Hospital, London, UK
Anthony Nolan Research Institute, London, UK;Cancer Institute, University College London, UK
Vol. 101 No. 3 (2016): March, 2016 https://doi.org/10.3324/haematol.2015.134999